An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease
Timothy J. Kendall(Edinburgh Royal Infirmary), Jonathan Fallowfield(Centre for Inflammation Research)
Cited by 69
Related Papers
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
|Journal of Hepatology|2023|92
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats
|Gut|2006|83
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
|Nature Reviews Gastroenterology & Hepatology|2023|70
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial
|PLoS Medicine|2017|64
Non-canonical Wnt signalling regulates scarring in biliary disease via the planar cell polarity receptors
|Nature Communications|2020|47